134 related articles for article (PubMed ID: 3280682)
1. Defective T lymphocytes in old mice. Diminished production of mature c-myc RNA after mitogen exposure not attributable to alterations in transcription or RNA stability.
Buckler AJ; Vie H; Sonenshein GE; Miller RA
J Immunol; 1988 Apr; 140(7):2442-6. PubMed ID: 3280682
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of cellular oncogene expression in mouse lymphocytes. I. Expression of c-myc and c-ras-Ha in T lymphocytes induced by various mitogens.
Schneider-Schaulies J; Hünig T; Schimpl A; Wecker E
Eur J Immunol; 1986 Mar; 16(3):312-6. PubMed ID: 3514240
[TBL] [Abstract][Full Text] [Related]
3. Decreased steady state c-myc mRNA in activated T cell cultures from old humans is caused by a smaller proportion of T cells that transcribe the c-myc gene.
Gamble DA; Schwab R; Weksler ME; Szabo P
J Immunol; 1990 May; 144(9):3569-73. PubMed ID: 2184192
[TBL] [Abstract][Full Text] [Related]
4. Two different molecular pathways account for low IL-2 receptor and c-myc mRNA expression by lpr Lyt-2- L3T4- T cells.
Katagiri K; Katagiri T; Yokota S; Eisenberg RA; Cohen PL; Ting JP
J Immunol; 1988 Sep; 141(6):2145-52. PubMed ID: 3139753
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression.
Schneider-Schaulies J; Schimpl A; Wecker E
Eur J Immunol; 1987 May; 17(5):713-8. PubMed ID: 3556196
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
Shipp MA; Reinherz EL
J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
[TBL] [Abstract][Full Text] [Related]
7. Cellular oncogenes and lymphocyte activation.
Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
[TBL] [Abstract][Full Text] [Related]
8. Distinct mechanisms of c-myc and lymphokine gene expression in an antigen specific T cell clone.
Heckford SE; Gelmann EP; Matis LA
Oncogene; 1988 Oct; 3(4):415-21. PubMed ID: 3152599
[TBL] [Abstract][Full Text] [Related]
9. Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes.
Wingett D; Reeves R; Magnuson NS
J Immunol; 1991 Nov; 147(10):3653-9. PubMed ID: 1940364
[TBL] [Abstract][Full Text] [Related]
10. Proto-oncogene expression in cloned T lymphocytes: mitogens and growth factors induce different patterns of expression.
Reed JC; Alpers JD; Scherle PA; Hoover RG; Nowell PC; Prystowsky MB
Oncogene; 1987 May; 1(2):223-8. PubMed ID: 3501855
[TBL] [Abstract][Full Text] [Related]
11. C-myc expression in lymphocytes of MRL/MP-lpr mice activated by A23187 and TPA.
Koizumi T; Nakao Y; Matsui T; Katakami Y; Mihara K; Takahashi R; Maeda S; Sugiyama T; Fujita T
Immunology; 1988 May; 64(1):93-6. PubMed ID: 3133310
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
[TBL] [Abstract][Full Text] [Related]
13. Effects of anti-proliferative cyclic AMP on interleukin 2-stimulated gene expression.
Farrar WL; Evans SW; Rapp UR; Cleveland JL
J Immunol; 1987 Sep; 139(6):2075-80. PubMed ID: 3040863
[TBL] [Abstract][Full Text] [Related]
14. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.
Nepveu A; Levine RA; Campisi J; Greenberg ME; Ziff EB; Marcu KB
Oncogene; 1987; 1(3):243-50. PubMed ID: 2455262
[TBL] [Abstract][Full Text] [Related]
15. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1.
Heikkila R; Schwab G; Wickstrom E; Loke SL; Pluznik DH; Watt R; Neckers LM
Nature; 1987 Jul 30-Aug 5; 328(6129):445-9. PubMed ID: 3302722
[TBL] [Abstract][Full Text] [Related]
16. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
Tavassoli M; Shall S
Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
[TBL] [Abstract][Full Text] [Related]
17. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional control of IL-2 and IL-4 in T cells of young and old mice.
Albright JW; Zúñiga-Pflücker JC; Albright JF
Cell Immunol; 1995 Sep; 164(2):170-5. PubMed ID: 7656324
[TBL] [Abstract][Full Text] [Related]
19. Cognate T cell help for CD40-deficient B cells induces c-myc RNA expression, but DNA synthesis requires an additional signal through surface Ig.
Schrader CE; Stavnezer J; Kikutani H; Parker DC
J Immunol; 1997 Jan; 158(1):153-62. PubMed ID: 8977186
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional control of c-myc gene expression during stimulation of murine B lymphocytes.
Buckler AJ; Rothstein TL; Sonenshein GE
J Immunol; 1990 Jul; 145(2):732-6. PubMed ID: 2195118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]